ICU Medical, Inc. (NASDAQ:ICUI) was downgraded by stock analysts at Roth Capital from a “buy” rating to a “neutral” rating in a report issued on Thursday, May 11th. The analysts noted that the move was a valuation call.
Separately, Zacks Investment Research lowered shares of ICU Medical from a “buy” rating to a “hold” rating in a research note on Monday, March 13th.
Shares of ICU Medical (ICUI) opened at 168.80 on Thursday. The company has a market capitalization of $3.34 billion, a PE ratio of 30.00 and a beta of 0.38. The company has a 50-day moving average of $162.41 and a 200 day moving average of $151.02. ICU Medical has a 52-week low of $103.21 and a 52-week high of $175.73.
ICU Medical (NASDAQ:ICUI) last issued its earnings results on Wednesday, May 10th. The medical instruments supplier reported $1.68 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.45 by $1.23. The business had revenue of $247.74 million for the quarter, compared to analyst estimates of $237.12 million. ICU Medical had a net margin of 18.76% and a return on equity of 9.63%. ICU Medical’s revenue was up 175.7% on a year-over-year basis. During the same period in the prior year, the firm earned $1.26 earnings per share. Analysts predict that ICU Medical will post $4.14 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: “Roth Capital Downgrades ICU Medical, Inc. (ICUI) to Neutral” was first published by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The original version of this news story can be read at https://www.com-unik.info/2017/06/17/icu-medical-incorporated-icui-rating-lowered-to-neutral-at-roth-capital-updated-updated-updated.html.
In other ICU Medical news, Director Joseph R. Saucedo sold 4,500 shares of the firm’s stock in a transaction on Tuesday, May 16th. The shares were sold at an average price of $162.51, for a total value of $731,295.00. Following the transaction, the director now directly owns 3,091 shares of the company’s stock, valued at $502,318.41. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Alison D. Burcar sold 18,290 shares of the stock in a transaction dated Wednesday, May 17th. The shares were sold at an average price of $160.72, for a total transaction of $2,939,568.80. Following the completion of the sale, the vice president now owns 3,727 shares of the company’s stock, valued at approximately $599,003.44. The disclosure for this sale can be found here. Insiders sold 23,384 shares of company stock worth $3,766,450 over the last ninety days. Insiders own 15.90% of the company’s stock.
Several hedge funds have recently made changes to their positions in ICUI. California State Teachers Retirement System increased its stake in shares of ICU Medical by 0.6% in the third quarter. California State Teachers Retirement System now owns 31,137 shares of the medical instruments supplier’s stock valued at $3,935,000 after buying an additional 200 shares in the last quarter. State of Tennessee Treasury Department increased its stake in shares of ICU Medical by 2.8% in the third quarter. State of Tennessee Treasury Department now owns 11,580 shares of the medical instruments supplier’s stock valued at $1,463,000 after buying an additional 315 shares in the last quarter. Municipal Employees Retirement System of Michigan increased its stake in shares of ICU Medical by 1.6% in the third quarter. Municipal Employees Retirement System of Michigan now owns 3,210 shares of the medical instruments supplier’s stock valued at $406,000 after buying an additional 50 shares in the last quarter. BlackRock Group LTD increased its stake in shares of ICU Medical by 2.4% in the third quarter. BlackRock Group LTD now owns 33,694 shares of the medical instruments supplier’s stock valued at $4,259,000 after buying an additional 775 shares in the last quarter. Finally, Rhumbline Advisers increased its stake in shares of ICU Medical by 5.6% in the third quarter. Rhumbline Advisers now owns 21,073 shares of the medical instruments supplier’s stock valued at $2,663,000 after buying an additional 1,119 shares in the last quarter. Institutional investors own 77.96% of the company’s stock.
About ICU Medical
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
What are top analysts saying about ICU Medical Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for ICU Medical Inc. and related companies.